A Diffusion Tensor Imaging Study on White Matter Abnormalities in Patients with Type 2 Diabetes Using Tract-Based Spatial Statistics

References

1. 1.↵
   2. Whiting DR,
   3. Guariguata L,
   4. Weil C, et al

   . IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311–21 doi:10.1016/j.diabres.2011.10.029 pmid:22079683

   CrossRefPubMed
2. 2.↵
   2. McCrimmon RJ,
   3. Ryan CM,
   4. Frier BM

   . Diabetes and cognitive dysfunction. Lancet 2012;379:2291–99 doi:10.1016/S0140-6736(12)60360-2 pmid:22683129

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Biessels GJ,
   3. Staekenborg S,
   4. Brunner E, et al

   . Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64–74 doi:10.1016/S1474-4422(05)70284-2 pmid:16361024

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Rusinek H,
   3. Ha J,
   4. Yau PL, et al

   . Cerebral perfusion in insulin resistance and type 2 diabetes. J Cereb Blood Flow Metab 2015;35:95–102 doi:10.1038/jcbfm.2014.173 pmid:25315860

   Abstract/FREE Full Text
5. 5.↵
   2. Sahin I,
   3. Alkan A,
   4. Keskin L, et al

   . Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complications 2008;22:254–60 doi:10.1016/j.jdiacomp.2007.03.007 pmid:18413166

   CrossRefPubMed
6. 6.↵
   2. Cui Y,
   3. Jiao Y,
   4. Chen YC, et al

   . Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study. Diabetes 2014;63:749–60 doi:10.2337/db13-0519 pmid:24353185

   Abstract/FREE Full Text
7. 7.↵
   2. Musen G,
   3. Jacobson AM,
   4. Bolo NR, et al

   . Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 2012;61:2375–79 doi:10.2337/db11-1669 pmid:22664957

   Abstract/FREE Full Text
8. 8.↵
   2. Umegaki H

   . Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clin Interv Aging 2014;9:1011–19 doi:10.2147/CIA.S48926 pmid:25061284

   CrossRefPubMed
9. 9.↵
   2. Zhang Y,
   3. Zhang X,
   4. Zhang J, et al

   . Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment. Neurosci Lett 2014;562:1–6 doi:10.1016/j.neulet.2014.01.006 pmid:24434688

   CrossRefPubMed
10. 10.↵
    2. de Bresser J,
    3. Tiehuis AM,
    4. van den Berg E, et al

    ; Utrecht Diabetic Encephalopathy Study Group. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010;33:1309–14 doi:10.2337/dc09-1923 pmid:20299484

    Abstract/FREE Full Text
11. 11.↵
    2. Moran C,
    3. Phan TG,
    4. Chen J, et al

    . Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013;36:4036–42 doi:10.2337/dc13-0143 pmid:23939539

    Abstract/FREE Full Text
12. 12.↵
    2. Antenor-Dorsey JA,
    3. Meyer E,
    4. Rutlin J, et al

    . White matter microstructural integrity in youth with type 1 diabetes. Diabetes 2013;62:581–89 doi:10.2337/db12-0696 pmid:23139349

    Abstract/FREE Full Text
13. 13.↵
    2. Nunley KA,
    3. Ryan CM,
    4. Orchard TJ, et al

    . White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes. Neurology 2015;84:2062–69 doi:10.1212/WNL.0000000000001582 pmid:25904692

    Abstract/FREE Full Text
14. 14.↵
    2. Stahl R,
    3. Dietrich O,
    4. Teipel SJ, et al

    . White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007;243:483–92 doi:10.1148/radiol.2432051714 pmid:17456872

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Hsu JL,
    3. Chen YL,
    4. Leu JG, et al

    . Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage 2012;59:1098–105 doi:10.1016/j.neuroimage.2011.09.041 pmid:21967726

    CrossRefPubMed
16. 16.↵
    2. Hoogenboom WS,
    3. Marder TJ,
    4. Flores VL, et al

    . Cerebral white matter integrity and resting-state functional connectivity in middle-aged patients with type 2 diabetes. Diabetes 2014;63:728–38 doi:10.2337/db13-1219 pmid:24203723

    Abstract/FREE Full Text
17. 17.↵
    2. Reijmer YD,
    3. Brundel M,
    4. de Bresser J, et al

    ; Utrecht Vascular Cognitive Impairment Study Group. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care 2013;36:137–44 doi:10.2337/dc12-0493 pmid:22961577

    Abstract/FREE Full Text
18. 18.↵
    2. Zhang J,
    3. Wang Y,
    4. Wang J, et al

    . White matter integrity disruptions associated with cognitive impairments in type 2 diabetic patients. Diabetes 2014;63:3596–605 doi:10.2337/db14-0342 pmid:24947353

    Abstract/FREE Full Text
19. 19.↵
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36(suppl 1):S67–74 doi:10.2337/dc13-S067 pmid:23264425

    FREE Full Text
20. 20.↵
    2. Jenkinson M,
    3. Beckmann CF,
    4. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Johansen-Berg H, et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505 doi:10.1016/j.neuroimage.2006.02.024 pmid:16624579

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Smith SM,
    3. Johansen-Berg H,
    4. Jenkinson M, et al

    . Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2007;2:499–503 doi:10.1038/nprot.2007.45 pmid:17406613

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Mori S,
    3. Oishi K,
    4. Jiang H, et al

    . Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 2008;40:570–82 doi:10.1016/j.neuroimage.2007.12.035 pmid:18255316

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Seib DR,
    3. Martin-Villalba A

    . Neurogenesis in the normal ageing hippocampus: a mini-review. Gerontology 2015;61:327–35 doi:10.1159/000368575 pmid:25471300

    CrossRefPubMed
25. 25.↵
    2. Chua TC,
    3. Wen W,
    4. Slavin MJ, et al

    . Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol 2008;21:83–92 doi:10.1097/WCO.0b013e3282f4594b pmid:18180656

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Liu Y,
    3. Spulber G,
    4. Lehtimäki KK, et al

    . Diffusion tensor imaging and tract-based spatial statistics in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2011;32:1558–71 doi:10.1016/j.neurobiolaging.2009.10.006 pmid:19913331

    CrossRefPubMed
27. 27.↵
    2. Menard SW

    . Applied Logistic Regression Analysis. Thousand Oaks, California: Sage; 2002:1–120
28. 28.↵
    2. Neil JJ

    . Diffusion imaging concepts for clinicians. J Magn Reson Imaging 2008;27:1–7 doi:10.1002/jmri.21087 pmid:18050325

    CrossRefPubMed
29. 29.↵
    2. Song SK,
    3. Sun SW,
    4. Ramsbottom MJ, et al

    . Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–36 doi:10.1006/nimg.2002.1267 pmid:12414282

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Peterson JW,
    3. Bö L,
    4. Mörk S, et al

    . Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400 doi:10.1002/ana.1123 pmid:11558796

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Biessels GJ,
    3. Deary IJ,
    4. Ryan CM

    . Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008;7:184–90 doi:10.1016/S1474-4422(08)70021-8 pmid:18207116

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Butterfield DA,
    3. Di Domenico F,
    4. Barone E

    . Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta 2014;1842:1693–706 doi:10.1016/j.bbadis.2014.06.010 pmid:24949886

    CrossRefPubMed